Head-to-head · WeighScore
BloomWell Rx vs Enhance MD
The verdict
Enhance MD takes it — 84.8/100 to 61.3/100.
Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | BloomWell Rx | Enhance MD |
|---|---|---|
| WeighScore | 61.3/100 | 84.8/100 |
| Grade | C | B |
| Site position | #335 | #5 |
| Semaglutide | $199/mo (starting dose, compounded) | $249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay |
| Tirzepatide | $249/mo (starting dose, compounded) | $329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay |
| Coverage | Coverage not published | Not publicly listed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Site position #335 · C
Strengths
- Transparent pricing — compounded semaglutide from $199/mo, tirzepatide (GLP-1/GIP) from $249/mo
- Free initial visit; fully online process with flexible dosing options
- Discloses meds are compounded by a licensed third-party pharmacy; also offers NAD+, sermorelin, glutathione
- Full legal suite published (Terms, Privacy, HIPAA Notice, Returns & Refunds)
Where it loses points
- 'Starts at' pricing — final cost depends on dose and plan
- Compounding pharmacy partner not named ('licensed third-party pharmacy')
- LegitScript certification was not documented on the public pages reviewed
- Operating medical entity not clearly named (site operated by a marketing agency)
Site position #5 · B
Strengths
- Transparent tiered pricing across sema, tirz, microdose, and combo
- Dose-flat — the price does not step up as you titrate
- Six-month lab testing plus provider-led care
- NAD+ longevity adjacency available
Where it loses points
- Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
- No oral or sublingual route
- States served are not published
- Higher entry price than the cheapest compounded programs
Featured provider
Enhance MD
Enhance MD scores 84.8/100 (B). A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.